Glucagon Stocks List
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
OZEM | D | Roundhill GLP-1 & Weight Loss ETF | 2.14 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 1.04 | |
BBC | B | Virtus LifeSci Biotech Clinical Trials ETF | 0.67 | |
CANC | C | Tema Oncology ETF | 0.63 | |
WCEO | A | Hypatia Women CEO ETF | 0.39 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Oct 31 | GPCR | Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024 |
- Glucagon
Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose and fatty acids in the bloodstream, and is considered to be the main catabolic hormone of the body. It is also used as a medication to treat a number of health conditions. Its effect is opposite to that of insulin, which lowers extracellular glucose. It is produced from proglucagon, encoded by the GCG gene.
The pancreas releases glucagon when the amount of glucose in the bloodstream is too low. Glucagon causes the liver to engage in glycogenolysis: converting stored glycogen into glucose, which is released into the bloodstream. High blood-glucose levels, on the other hand, stimulate the release of insulin. Insulin allows glucose to be taken up and used by insulin-dependent tissues. Thus, glucagon and insulin are part of a feedback system that keeps blood glucose levels stable. Glucagon increases energy expenditure and is elevated under conditions of stress. Glucagon belongs to the secretin family of hormones.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles